Curanex Pharmaceuticals Inc (CURX)
8.60
+0.41 (4.95%)
Inactive · Last trade price on Sep 12, 2025
Curanex Pharmaceuticals Statistics
Total Valuation
CURX has a market cap or net worth of $238.51 million. The enterprise value is $235.69 million.
| Market Cap | 238.51M |
| Enterprise Value | 235.69M |
Important Dates
The last earnings date was Tuesday, September 9, 2025.
| Earnings Date | Sep 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CURX has 27.75 million shares outstanding. The number of shares has increased by 1,503.93% in one year.
| Current Share Class | 27.75M |
| Shares Outstanding | 27.75M |
| Shares Change (YoY) | +1,503.93% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 69.26% |
| Owned by Institutions (%) | n/a |
| Float | 8.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 770.45 |
| P/TBV Ratio | 770.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.37, with a Debt / Equity ratio of 1.56.
| Current Ratio | 9.37 |
| Quick Ratio | 1.43 |
| Debt / Equity | 1.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -81.20 |
Financial Efficiency
Return on equity (ROE) is -85.25% and return on invested capital (ROIC) is -30.15%.
| Return on Equity (ROE) | -85.25% |
| Return on Assets (ROA) | -30.03% |
| Return on Invested Capital (ROIC) | -30.15% |
| Return on Capital Employed (ROCE) | -50.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 2,694,903 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -361,095 |
| Pretax Income | n/a |
| Net Income | -435,034 |
| EBITDA | n/a |
| EBIT | -361,095 |
| Earnings Per Share (EPS) | -$0.02 |
Balance Sheet
The company has $108,862 in cash and $476,452 in debt, giving a net cash position of -$367,590 or -$0.01 per share.
| Cash & Cash Equivalents | 108,862 |
| Total Debt | 476,452 |
| Net Cash | -367,590 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | 305,431 |
| Book Value Per Share | 0.01 |
| Working Capital | 635,410 |
Cash Flow
| Operating Cash Flow | -665,399 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CURX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,503.93% |
| Shareholder Yield | -1,503.93% |
| Earnings Yield | -0.18% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |